Superoxide dismutase promotes gastric tumorigenesis mediated by and enhances resistance to 5-fluorouracil in gastric cancer.
() infection is the most common risk factor for gastric cancer (GC).
APA
Fu H, Zhang Y, et al. (2025). Superoxide dismutase promotes gastric tumorigenesis mediated by and enhances resistance to 5-fluorouracil in gastric cancer.. iScience, 28(2), 111553. https://doi.org/10.1016/j.isci.2024.111553
MLA
Fu H, et al.. "Superoxide dismutase promotes gastric tumorigenesis mediated by and enhances resistance to 5-fluorouracil in gastric cancer.." iScience, vol. 28, no. 2, 2025, pp. 111553.
PMID
39898027
Abstract
() infection is the most common risk factor for gastric cancer (GC). The effect of the antioxidase manganese superoxide dismutase (SOD2) in gastric tumorigenesis remains unclear. We explored the molecular mechanisms of links between , inflammation, and SOD2 in GC. We found that SOD2 was upregulated in GC. GC patients with high SOD2 expression showed worse overall survival. infection promoted SOD2 expression by transcriptionally activating the NF-κB signaling pathway. Knockdown of SOD2 led to increased levels of reactive oxygen species and oxidative stress in response to infection. Our research demonstrates that SOD2 can serve as an inhibitor of ferroptosis by activating AKT, and stabilizing GPX4 protein, which subsequently induces 5-fluorouracil resistance. These findings reveal a mechanism whereby can promote gastric carcinogenesis by activating the NF-κB/SOD2/AKT/GPX4 pathway, leading to the inhibition of ferroptosis. This may provide a promising therapeutic target for GC.
같은 제1저자의 인용 많은 논문 (5)
- [Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era].
- A smart gene circuit for precise regulation of tumor cell behavior.
- Early gastric cancer with malignant invasion into the duodenum: A case report.
- Pioneering preoperative anti-PD-1 immunotherapy enables curative resection in dMMR advanced/recurrent endometrial carcinoma: a case series (2020-2022).
- Integrating intratumoral, peritumoral, and clinical features in an ultrasound-based radiomics model: contributions and synergies for predicting microvascular invasion in hepatocellular carcinoma.